跳至主要内容
临床试验/NCT00073697
NCT00073697已完成4 期

Depression: The Search for Treatment-Relevant Phenotypes

University of Pittsburgh2 个研究点 分布在 2 个国家目标入组 290 人开始时间: 2003年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
290
试验地点
2
主要终点
Hamilton Rating Scale for Depression score

研究概览

简要总结

This study will determine how certain features of depressed individuals affect their responses to depression treatment.

详细描述

Major depression is a serious condition that can have devastating functional consequences. Although numerous depression studies have been conducted, understanding of how best to achieve long-term recovery remains limited. This study will assess the mood, personality, pharamcokinetic and genetic characteristics of depressed participants to determine the effects of these features on treatment response.

This study will be conducted at two international treatment sites, including the University of Pittsburgh and the University of Pisa, Italy. Participants will be randomly assigned to receive either interpersonal psychotherapy (IPT) or escitalopram pharmacotherapy for a minimum of 32 weeks or approximately 8 months. Participants whose symptoms become stabilized will continue the initial treatment for another 6 months; those who do not will have the second treatment added to their regimen until remission occurs. Clinical evaluations and questionnaires will be used to assess participants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 66 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Major depression

排除标准

  • History of manic or hypomanic episodes
  • History of schizophrenia or schizoaffective disorder
  • Diagnosis of anorexia nervosa or bulimia nervosa
  • Current psychosis
  • Drug and/or alcohol dependence or abuse within 3 months prior to study entry. Participants with episodic abuse related to mood disorders will not be excluded.
  • Diagnosis of antisocial personality disorder
  • Diagnosis of organic affective syndrome and uncontrolled medical illness
  • Pregnancy
  • Require inpatient treatment for suicidal risk or psychosis
  • History of an inability to tolerate any of the study treatments
  • Currently receiving treatment with an effective antidepressant

研究组 & 干预措施

1

Experimental

Interpersonal Psychotherapy

干预措施: Interpersonal Psychotherapy (Behavioral)

2

Experimental

Escitalopram

干预措施: Escitalopram (Drug)

3

Experimental

Escitalopram plus IPT

干预措施: Escitalopram plus IPT (Other)

结局指标

主要结局

Hamilton Rating Scale for Depression score

时间窗: Measured at Months 8 and 14

Treatment-relevant phenotypes of depression

时间窗: Measured at Months 8 and 14

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验